The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Implantable Drug-Eluting Devices Market Research Report 2025

Global Implantable Drug-Eluting Devices Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1925250

No of Pages : 95

Ask Your Query
Synopsis
Implantable drug-eluting devices offer several unique advantages over conventional oral or parenteral drug delivery methods.
The global Implantable Drug-Eluting Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Implantable Drug-Eluting Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Drug-Eluting Devices.
Report Scope
The Implantable Drug-Eluting Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Implantable Drug-Eluting Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Implantable Drug-Eluting Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Medtronic
Merck
Bayer AG
Johnson & Johnson
Abbott
Surmodics
Boston Scientific Corporation
Titan Pharmaceuticals, Inc.
BIOTRONIK
Allergan
Bausch & Lomb
REVA Medical
MicroPort Medical
Segment by Type
Implantable Drug Infusion Pumps
Intraocular Drug-Eluting Devices
Contraceptive Drug-Eluting Devices
Drug-Eluting Stents
Others
Segment by Application
Diabetes
Contraception
HIV/AIDS Prevention
Chronic Pain Management
Cardiovascular
Ophthalmology
Oncology
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Implantable Drug-Eluting Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Implantable Drug-Eluting Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Implantable Drug-Eluting Devices Market Overview
1.1 Product Overview and Scope of Implantable Drug-Eluting Devices
1.2 Implantable Drug-Eluting Devices Segment by Type
1.2.1 Global Implantable Drug-Eluting Devices Market Value Comparison by Type (2024-2030)
1.2.2 Implantable Drug Infusion Pumps
1.2.3 Intraocular Drug-Eluting Devices
1.2.4 Contraceptive Drug-Eluting Devices
1.2.5 Drug-Eluting Stents
1.2.6 Others
1.3 Implantable Drug-Eluting Devices Segment by Application
1.3.1 Global Implantable Drug-Eluting Devices Market Value by Application: (2024-2030)
1.3.2 Diabetes
1.3.3 Contraception
1.3.4 HIV/AIDS Prevention
1.3.5 Chronic Pain Management
1.3.6 Cardiovascular
1.3.7 Ophthalmology
1.3.8 Oncology
1.3.9 Others
1.4 Global Implantable Drug-Eluting Devices Market Size Estimates and Forecasts
1.4.1 Global Implantable Drug-Eluting Devices Revenue 2019-2030
1.4.2 Global Implantable Drug-Eluting Devices Sales 2019-2030
1.4.3 Global Implantable Drug-Eluting Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Implantable Drug-Eluting Devices Market Competition by Manufacturers
2.1 Global Implantable Drug-Eluting Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Implantable Drug-Eluting Devices Average Price by Manufacturers (2019-2024)
2.4 Global Implantable Drug-Eluting Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Implantable Drug-Eluting Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Implantable Drug-Eluting Devices, Product Type & Application
2.7 Implantable Drug-Eluting Devices Market Competitive Situation and Trends
2.7.1 Implantable Drug-Eluting Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Implantable Drug-Eluting Devices Players Market Share by Revenue
2.7.3 Global Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Implantable Drug-Eluting Devices Retrospective Market Scenario by Region
3.1 Global Implantable Drug-Eluting Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Implantable Drug-Eluting Devices Global Implantable Drug-Eluting Devices Sales by Region: 2019-2030
3.2.1 Global Implantable Drug-Eluting Devices Sales by Region: 2019-2024
3.2.2 Global Implantable Drug-Eluting Devices Sales by Region: 2025-2030
3.3 Global Implantable Drug-Eluting Devices Global Implantable Drug-Eluting Devices Revenue by Region: 2019-2030
3.3.1 Global Implantable Drug-Eluting Devices Revenue by Region: 2019-2024
3.3.2 Global Implantable Drug-Eluting Devices Revenue by Region: 2025-2030
3.4 North America Implantable Drug-Eluting Devices Market Facts & Figures by Country
3.4.1 North America Implantable Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Implantable Drug-Eluting Devices Sales by Country (2019-2030)
3.4.3 North America Implantable Drug-Eluting Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Implantable Drug-Eluting Devices Market Facts & Figures by Country
3.5.1 Europe Implantable Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Implantable Drug-Eluting Devices Sales by Country (2019-2030)
3.5.3 Europe Implantable Drug-Eluting Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Implantable Drug-Eluting Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Implantable Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Implantable Drug-Eluting Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Implantable Drug-Eluting Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Implantable Drug-Eluting Devices Market Facts & Figures by Country
3.7.1 Latin America Implantable Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Implantable Drug-Eluting Devices Sales by Country (2019-2030)
3.7.3 Latin America Implantable Drug-Eluting Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Implantable Drug-Eluting Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Implantable Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Implantable Drug-Eluting Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Implantable Drug-Eluting Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Implantable Drug-Eluting Devices Sales by Type (2019-2030)
4.1.1 Global Implantable Drug-Eluting Devices Sales by Type (2019-2024)
4.1.2 Global Implantable Drug-Eluting Devices Sales by Type (2025-2030)
4.1.3 Global Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2030)
4.2 Global Implantable Drug-Eluting Devices Revenue by Type (2019-2030)
4.2.1 Global Implantable Drug-Eluting Devices Revenue by Type (2019-2024)
4.2.2 Global Implantable Drug-Eluting Devices Revenue by Type (2025-2030)
4.2.3 Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2019-2030)
4.3 Global Implantable Drug-Eluting Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Implantable Drug-Eluting Devices Sales by Application (2019-2030)
5.1.1 Global Implantable Drug-Eluting Devices Sales by Application (2019-2024)
5.1.2 Global Implantable Drug-Eluting Devices Sales by Application (2025-2030)
5.1.3 Global Implantable Drug-Eluting Devices Sales Market Share by Application (2019-2030)
5.2 Global Implantable Drug-Eluting Devices Revenue by Application (2019-2030)
5.2.1 Global Implantable Drug-Eluting Devices Revenue by Application (2019-2024)
5.2.2 Global Implantable Drug-Eluting Devices Revenue by Application (2025-2030)
5.2.3 Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2019-2030)
5.3 Global Implantable Drug-Eluting Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Implantable Drug-Eluting Devices Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Implantable Drug-Eluting Devices Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Implantable Drug-Eluting Devices Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Bayer AG
6.4.1 Bayer AG Corporation Information
6.4.2 Bayer AG Description and Business Overview
6.4.3 Bayer AG Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer AG Implantable Drug-Eluting Devices Product Portfolio
6.4.5 Bayer AG Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Abbott Implantable Drug-Eluting Devices Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 Surmodics
6.6.1 Surmodics Corporation Information
6.6.2 Surmodics Description and Business Overview
6.6.3 Surmodics Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Surmodics Implantable Drug-Eluting Devices Product Portfolio
6.7.5 Surmodics Recent Developments/Updates
6.8 Boston Scientific Corporation
6.8.1 Boston Scientific Corporation Corporation Information
6.8.2 Boston Scientific Corporation Description and Business Overview
6.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Product Portfolio
6.8.5 Boston Scientific Corporation Recent Developments/Updates
6.9 Titan Pharmaceuticals, Inc.
6.9.1 Titan Pharmaceuticals, Inc. Corporation Information
6.9.2 Titan Pharmaceuticals, Inc. Description and Business Overview
6.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product Portfolio
6.9.5 Titan Pharmaceuticals, Inc. Recent Developments/Updates
6.10 BIOTRONIK
6.10.1 BIOTRONIK Corporation Information
6.10.2 BIOTRONIK Description and Business Overview
6.10.3 BIOTRONIK Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 BIOTRONIK Implantable Drug-Eluting Devices Product Portfolio
6.10.5 BIOTRONIK Recent Developments/Updates
6.11 Allergan
6.11.1 Allergan Corporation Information
6.11.2 Allergan Implantable Drug-Eluting Devices Description and Business Overview
6.11.3 Allergan Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Allergan Implantable Drug-Eluting Devices Product Portfolio
6.11.5 Allergan Recent Developments/Updates
6.12 Bausch & Lomb
6.12.1 Bausch & Lomb Corporation Information
6.12.2 Bausch & Lomb Implantable Drug-Eluting Devices Description and Business Overview
6.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Bausch & Lomb Implantable Drug-Eluting Devices Product Portfolio
6.12.5 Bausch & Lomb Recent Developments/Updates
6.13 REVA Medical
6.13.1 REVA Medical Corporation Information
6.13.2 REVA Medical Implantable Drug-Eluting Devices Description and Business Overview
6.13.3 REVA Medical Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 REVA Medical Implantable Drug-Eluting Devices Product Portfolio
6.13.5 REVA Medical Recent Developments/Updates
6.14 MicroPort Medical
6.14.1 MicroPort Medical Corporation Information
6.14.2 MicroPort Medical Implantable Drug-Eluting Devices Description and Business Overview
6.14.3 MicroPort Medical Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.14.4 MicroPort Medical Implantable Drug-Eluting Devices Product Portfolio
6.14.5 MicroPort Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Implantable Drug-Eluting Devices Industry Chain Analysis
7.2 Implantable Drug-Eluting Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Implantable Drug-Eluting Devices Production Mode & Process
7.4 Implantable Drug-Eluting Devices Sales and Marketing
7.4.1 Implantable Drug-Eluting Devices Sales Channels
7.4.2 Implantable Drug-Eluting Devices Distributors
7.5 Implantable Drug-Eluting Devices Customers
8 Implantable Drug-Eluting Devices Market Dynamics
8.1 Implantable Drug-Eluting Devices Industry Trends
8.2 Implantable Drug-Eluting Devices Market Drivers
8.3 Implantable Drug-Eluting Devices Market Challenges
8.4 Implantable Drug-Eluting Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Implantable Drug-Eluting Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Implantable Drug-Eluting Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Implantable Drug-Eluting Devices Market Competitive Situation by Manufacturers in 2023
Table 4. Global Implantable Drug-Eluting Devices Sales (Units) of Key Manufacturers (2019-2024)
Table 5. Global Implantable Drug-Eluting Devices Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Implantable Drug-Eluting Devices Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Implantable Drug-Eluting Devices Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Implantable Drug-Eluting Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Implantable Drug-Eluting Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Implantable Drug-Eluting Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Implantable Drug-Eluting Devices, Product Type & Application
Table 12. Global Key Manufacturers of Implantable Drug-Eluting Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Implantable Drug-Eluting Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Drug-Eluting Devices as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Implantable Drug-Eluting Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Implantable Drug-Eluting Devices Sales by Region (2019-2024) & (Units)
Table 18. Global Implantable Drug-Eluting Devices Sales Market Share by Region (2019-2024)
Table 19. Global Implantable Drug-Eluting Devices Sales by Region (2025-2030) & (Units)
Table 20. Global Implantable Drug-Eluting Devices Sales Market Share by Region (2025-2030)
Table 21. Global Implantable Drug-Eluting Devices Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2019-2024)
Table 23. Global Implantable Drug-Eluting Devices Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2025-2030)
Table 25. North America Implantable Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Implantable Drug-Eluting Devices Sales by Country (2019-2024) & (Units)
Table 27. North America Implantable Drug-Eluting Devices Sales by Country (2025-2030) & (Units)
Table 28. North America Implantable Drug-Eluting Devices Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Implantable Drug-Eluting Devices Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Implantable Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Implantable Drug-Eluting Devices Sales by Country (2019-2024) & (Units)
Table 32. Europe Implantable Drug-Eluting Devices Sales by Country (2025-2030) & (Units)
Table 33. Europe Implantable Drug-Eluting Devices Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Implantable Drug-Eluting Devices Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Implantable Drug-Eluting Devices Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Implantable Drug-Eluting Devices Sales by Region (2019-2024) & (Units)
Table 37. Asia Pacific Implantable Drug-Eluting Devices Sales by Region (2025-2030) & (Units)
Table 38. Asia Pacific Implantable Drug-Eluting Devices Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Implantable Drug-Eluting Devices Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Implantable Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Implantable Drug-Eluting Devices Sales by Country (2019-2024) & (Units)
Table 42. Latin America Implantable Drug-Eluting Devices Sales by Country (2025-2030) & (Units)
Table 43. Latin America Implantable Drug-Eluting Devices Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Implantable Drug-Eluting Devices Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Implantable Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Implantable Drug-Eluting Devices Sales by Country (2019-2024) & (Units)
Table 47. Middle East & Africa Implantable Drug-Eluting Devices Sales by Country (2025-2030) & (Units)
Table 48. Middle East & Africa Implantable Drug-Eluting Devices Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Implantable Drug-Eluting Devices Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Implantable Drug-Eluting Devices Sales (Units) by Type (2019-2024)
Table 51. Global Implantable Drug-Eluting Devices Sales (Units) by Type (2025-2030)
Table 52. Global Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Table 53. Global Implantable Drug-Eluting Devices Sales Market Share by Type (2025-2030)
Table 54. Global Implantable Drug-Eluting Devices Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Implantable Drug-Eluting Devices Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2019-2024)
Table 57. Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2025-2030)
Table 58. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Type (2019-2024)
Table 59. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Type (2025-2030)
Table 60. Global Implantable Drug-Eluting Devices Sales (Units) by Application (2019-2024)
Table 61. Global Implantable Drug-Eluting Devices Sales (Units) by Application (2025-2030)
Table 62. Global Implantable Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Table 63. Global Implantable Drug-Eluting Devices Sales Market Share by Application (2025-2030)
Table 64. Global Implantable Drug-Eluting Devices Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Implantable Drug-Eluting Devices Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2019-2024)
Table 67. Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2025-2030)
Table 68. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Application (2019-2024)
Table 69. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Implantable Drug-Eluting Devices Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Medtronic Corporation Information
Table 76. Medtronic Description and Business Overview
Table 77. Medtronic Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Medtronic Implantable Drug-Eluting Devices Product
Table 79. Medtronic Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Merck Implantable Drug-Eluting Devices Product
Table 84. Merck Recent Developments/Updates
Table 85. Bayer AG Corporation Information
Table 86. Bayer AG Description and Business Overview
Table 87. Bayer AG Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Bayer AG Implantable Drug-Eluting Devices Product
Table 89. Bayer AG Recent Developments/Updates
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Johnson & Johnson Implantable Drug-Eluting Devices Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. Abbott Corporation Information
Table 96. Abbott Description and Business Overview
Table 97. Abbott Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Abbott Implantable Drug-Eluting Devices Product
Table 99. Abbott Recent Developments/Updates
Table 100. Surmodics Corporation Information
Table 101. Surmodics Description and Business Overview
Table 102. Surmodics Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Surmodics Implantable Drug-Eluting Devices Product
Table 104. Surmodics Recent Developments/Updates
Table 105. Boston Scientific Corporation Corporation Information
Table 106. Boston Scientific Corporation Description and Business Overview
Table 107. Boston Scientific Corporation Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Boston Scientific Corporation Implantable Drug-Eluting Devices Product
Table 109. Boston Scientific Corporation Recent Developments/Updates
Table 110. Titan Pharmaceuticals, Inc. Corporation Information
Table 111. Titan Pharmaceuticals, Inc. Description and Business Overview
Table 112. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product
Table 114. Titan Pharmaceuticals, Inc. Recent Developments/Updates
Table 115. BIOTRONIK Corporation Information
Table 116. BIOTRONIK Description and Business Overview
Table 117. BIOTRONIK Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. BIOTRONIK Implantable Drug-Eluting Devices Product
Table 119. BIOTRONIK Recent Developments/Updates
Table 120. Allergan Corporation Information
Table 121. Allergan Description and Business Overview
Table 122. Allergan Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Allergan Implantable Drug-Eluting Devices Product
Table 124. Allergan Recent Developments/Updates
Table 125. Bausch & Lomb Corporation Information
Table 126. Bausch & Lomb Description and Business Overview
Table 127. Bausch & Lomb Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Bausch & Lomb Implantable Drug-Eluting Devices Product
Table 129. Bausch & Lomb Recent Developments/Updates
Table 130. REVA Medical Corporation Information
Table 131. REVA Medical Description and Business Overview
Table 132. REVA Medical Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. REVA Medical Implantable Drug-Eluting Devices Product
Table 134. REVA Medical Recent Developments/Updates
Table 135. MicroPort Medical Corporation Information
Table 136. MicroPort Medical Description and Business Overview
Table 137. MicroPort Medical Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. MicroPort Medical Implantable Drug-Eluting Devices Product
Table 139. MicroPort Medical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Implantable Drug-Eluting Devices Distributors List
Table 143. Implantable Drug-Eluting Devices Customers List
Table 144. Implantable Drug-Eluting Devices Market Trends
Table 145. Implantable Drug-Eluting Devices Market Drivers
Table 146. Implantable Drug-Eluting Devices Market Challenges
Table 147. Implantable Drug-Eluting Devices Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Implantable Drug-Eluting Devices
Figure 2. Global Implantable Drug-Eluting Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Implantable Drug-Eluting Devices Market Share by Type in 2023 & 2030
Figure 4. Implantable Drug Infusion Pumps Product Picture
Figure 5. Intraocular Drug-Eluting Devices Product Picture
Figure 6. Contraceptive Drug-Eluting Devices Product Picture
Figure 7. Drug-Eluting Stents Product Picture
Figure 8. Others Product Picture
Figure 9. Global Implantable Drug-Eluting Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Implantable Drug-Eluting Devices Market Share by Application in 2023 & 2030
Figure 11. Diabetes
Figure 12. Contraception
Figure 13. HIV/AIDS Prevention
Figure 14. Chronic Pain Management
Figure 15. Cardiovascular
Figure 16. Ophthalmology
Figure 17. Oncology
Figure 18. Others
Figure 19. Global Implantable Drug-Eluting Devices Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Implantable Drug-Eluting Devices Market Size (2019-2030) & (US$ Million)
Figure 21. Global Implantable Drug-Eluting Devices Sales (2019-2030) & (Units)
Figure 22. Global Implantable Drug-Eluting Devices Average Price (USD/Unit) & (2019-2030)
Figure 23. Implantable Drug-Eluting Devices Report Years Considered
Figure 24. Implantable Drug-Eluting Devices Sales Share by Manufacturers in 2023
Figure 25. Global Implantable Drug-Eluting Devices Revenue Share by Manufacturers in 2023
Figure 26. The Global 5 and 10 Largest Implantable Drug-Eluting Devices Players: Market Share by Revenue in 2023
Figure 27. Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 28. Global Implantable Drug-Eluting Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 29. North America Implantable Drug-Eluting Devices Sales Market Share by Country (2019-2030)
Figure 30. North America Implantable Drug-Eluting Devices Revenue Market Share by Country (2019-2030)
Figure 31. U.S. Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Canada Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Europe Implantable Drug-Eluting Devices Sales Market Share by Country (2019-2030)
Figure 34. Europe Implantable Drug-Eluting Devices Revenue Market Share by Country (2019-2030)
Figure 35. Germany Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. France Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. U.K. Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Italy Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Russia Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Asia Pacific Implantable Drug-Eluting Devices Sales Market Share by Region (2019-2030)
Figure 41. Asia Pacific Implantable Drug-Eluting Devices Revenue Market Share by Region (2019-2030)
Figure 42. China Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Japan Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. South Korea Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. India Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Australia Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Taiwan Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Indonesia Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Thailand Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Malaysia Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Philippines Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Latin America Implantable Drug-Eluting Devices Sales Market Share by Country (2019-2030)
Figure 53. Latin America Implantable Drug-Eluting Devices Revenue Market Share by Country (2019-2030)
Figure 54. Mexico Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Brazil Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Argentina Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Country (2019-2030)
Figure 58. Middle East & Africa Implantable Drug-Eluting Devices Revenue Market Share by Country (2019-2030)
Figure 59. Turkey Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. Saudi Arabia Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 61. U.A.E Implantable Drug-Eluting Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 62. Global Sales Market Share of Implantable Drug-Eluting Devices by Type (2019-2030)
Figure 63. Global Revenue Market Share of Implantable Drug-Eluting Devices by Type (2019-2030)
Figure 64. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Type (2019-2030)
Figure 65. Global Sales Market Share of Implantable Drug-Eluting Devices by Application (2019-2030)
Figure 66. Global Revenue Market Share of Implantable Drug-Eluting Devices by Application (2019-2030)
Figure 67. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Application (2019-2030)
Figure 68. Implantable Drug-Eluting Devices Value Chain
Figure 69. Implantable Drug-Eluting Devices Production Process
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Distributors Profiles
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock